Evidence map›Paper›PMID 36319445›Full record

ArticleSmall methods2022

An Advanced Thermal Decomposition Method to Produce Magnetic Nanoparticles with Ultrahigh Heating Efficiency for Systemic Magnetic Hyperthermia.

Ananiya A Demessie, Youngrong Park, Prem Singh, Abraham S Moses, Tetiana Korzun, Fahad Y Sabei, Hassan A Albarqi, Leonardo Campos, Cory R Wyatt, Khashayar Farsad and 4 more

Open access · greenAbstract read
In one paragraph

Article in Small methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Ananiya A DemessieDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Youngrong ParkDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Prem SinghDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Abraham S MosesDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Tetiana KorzunDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Fahad Y SabeiDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Hassan A AlbarqiDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Leonardo CamposDotter Interventional Institute, Department of Interventional Radiology, Oregon Health & Science University, Portland, OR, 97239, USA.
Cory R WyattDepartment of Diagnostic Radiology, Oregon Health & Sciences University, Portland, OR, 97239, USA.
Khashayar FarsadDotter Interventional Institute, Department of Interventional Radiology, Oregon Health & Science University, Portland, OR, 97239, USA.
Pallavi DhagatSchool of Electrical Engineering and Computer Science, Oregon State University, Corvallis, OR, 97331, USA.
Conroy SunDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Olena R TaratulaDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Oleh TaratulaDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.ORCID 0000-0002-6227-9110
Oregon State University · USOregon Health & Science University · US

Funding

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer CachexiaR37CA234006 · NCI · OREGON STATE UNIVERSITY · PI TARATULA, OLEH · 2019 to 2025
$3.2M
Intravascular Delivery of Nanoclusters for Treatment of Deep-Seated Cancers with Magnetic HyperthermiaR01CA237569 · NCI · OREGON STATE UNIVERSITY · PI TARATULA, OLEH · 2020 to 2024
$2.7M
Development of magnetic hyperthermia for the systemic treatment of endometriosisR01HD101450 · NICHD · OREGON STATE UNIVERSITY · PI SLAYDEN, OV D, TARATULA, OLEH · 2021 to 2024
$2.4M
Accelerator Innovation DevelopmentAdvanced Materials Research CenterIndian Institute of Technology MandiNational Institute of Child Health and Human Development R01HD101450NCI NIH HHS R01 CA237569NCI NIH HHS R37 CA234006NICHD NIH HHS R01 HD101450NIH HHS R01CA237569NIH HHS R37CA234006
6 · The paper itself

Abstract

Due to the limited heating efficiency of available magnetic nanoparticles, it is difficult to achieve therapeutic temperatures above 44 °C in relatively inaccessible tumors during magnetic hyperthermia following systemic administration of nanoparticles at clinical dosage (≤10 mg kg

Indexed as

Hyperthermia, InducedMagnetite NanoparticlesNeoplasmsAnimalsHeatingHyperthermiaMagnetic FieldsMiceNitrogenMagnetite NanoparticlesNitrogenAMFLHRH peptidesmagnetic hyperthermiananoparticlesovarian cancer

Identifiers

PMID36319445
PMCPMC9772135
OpenAlexW4307966547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.